Phase I/II Trial of Cord Blood-Derived NK Cells Genetically Engineered With NY-ESO-1 TCR/IL-15 Cell Receptor for Relapsed/Refractory Multiple Myeloma
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Maryland, Baltimore
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute